Abstract
The aim of the present study was to evaluate whether in ankylosing spondylitis (AS), interleukin-6 (IL-6) is a reliable predictor of changes in mobility in the subsequent year. Of 261 AS patients who had been enrolled in a previous study, 128 returned for treatment at our health centre after 1 year (±3 months). The variables for mobility after 1 year (II) were compared with the findings of the previous year (I). Differences in parameters for mobility were related to the serum concentration of IL-6 in the previous year. Relation between serum concentration of IL-6 and difference (II–I) in occiput-to-wall distance (Spearman's rank correlation coefficient r s, P value) was 0.02, 0.82; chin–chest distance −0.09, 0.31; cervical rotation −0.08, 0.39; chest expansion 0.05, 0.54; finger–floor distance −0.02, 0.84; Ott sign (flexibility of the thoracic spine) −0.11, 0.22; Schober sign 0.01, 0.94. After 1 year there was a significant improvement in cervical rotation in patients with low IL-6 serum concentration (lower quartile), but not in those with high levels of IL-6 (upper quartile). No further difference was seen between patients with high or low levels of IL-6. The present data suggest that the serum concentration of IL-6 does not allow a prediction of disease progression in the subsequent year.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 15 September 1999 / Accepted: 20 January 2000
Rights and permissions
About this article
Cite this article
Falkenbach, A., Herold, M. & Wigand, R. Interleukin-6 serum concentration in ankylosing spondylitis: a reliable predictor of disease progression in the subsequent year?. Rheumatology International 19, 149–151 (2000). https://doi.org/10.1007/s002960050119
Issue Date:
DOI: https://doi.org/10.1007/s002960050119